Literature DB >> 7856692

Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta.

N Kato1, A Nawa, K Tamakoshi, F Kikkawa, N Suganuma, T Okamoto, S Goto, Y Tomoda, M Hamaguchi, M Nakajima.   

Abstract

OBJECTIVE: Choriocarcinoma is a highly invasive gynecologic tumor, and hematogenous metastases frequently develop. To establish a molecular basis for antiinvasion therapy of choriocarcinoma, we examined the effects of human recombinant interferons on gelatinase production and invasion by choriocarcinoma cells. STUDY
DESIGN: Using five choriocarcinoma cell lines, we measured gelatinase activity by gelatin zymography. The effects of recombinant interferons (rIFN-alpha, rIFN-beta, and rIFN-gamma) were then analyzed by Western blot analysis and chemoinvasion assay.
RESULTS: High levels of 72 kd gelatinase activity were detected in the highly invasive choriocarcinoma cell lines, two of which also contained an active form of 72 kd gelatinase with an apparent molecular mass of 68 kd. Gelatinase production was decreased by incubation with rIFN-beta. In the chemoinvasion assay, only rIFN-beta had an inhibitory effect on the invasiveness of tumor cells without a cytotoxic effect.
CONCLUSION: Choriocarcinoma cells showed high 72 kd gelatinase activity, which suggested a role for the enzyme in vascular metastasis. Studies on the use of rIFN-beta to inhibit metastasis of choriocarcinoma via suppression of gelatinase production are warranted.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856692     DOI: 10.1016/0002-9378(95)90579-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response.

Authors:  C Rozera; D Carlei; P L Lollini; C De Giovanni; P Musiani; E Di Carlo; F Belardelli; M Ferrantini
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach.

Authors:  A Albini; C Marchisone; F Del Grosso; R Benelli; L Masiello; C Tacchetti; M Bono; M Ferrantini; C Rozera; M Truini; F Belardelli; L Santi; D M Noonan
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

3.  Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice.

Authors:  Lu Wang; Wei-Zhong Wu; Hui-Chuan Sun; Xiao-Feng Wu; Lun-Xiu Qin; Yin-Kun Liu; Kang-Da Liu; Zhao-You Tang
Journal:  J Gastrointest Surg       Date:  2003 Jul-Aug       Impact factor: 3.452

4.  Evidence for the causal role of endogenous interferon-alpha/beta in the regulation of angiogenesis, tumorigenicity, and metastasis of cutaneous neoplasms.

Authors:  Marya F McCarty; Diane Bielenberg; Cherrie Donawho; Corazon D Bucana; Isaiah J Fidler
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

5.  Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.

Authors:  S Tomozawa; H Nagawa; N Tsuno; K Hatano; T Osada; J Kitayama; E Sunami; M E Nita; S Ishihara; H Yano; T Tsuruo; Y Shibata; T Muto
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.